Abstract
Identifying persons who are least willing to receive a coronavirus disease 2019 (COVID-19) vaccine is critical for increasing uptake via targeted outreach. We conducted a survey of 23,819 Canadian Longitudinal Study on Aging participants from September 29 to December 29, 2020, to assess factors associated with COVID-19 vaccination willingness and reasons for willingness or lack thereof. Among adults aged 50-96 years, 84.1% (95% confidence interval (CI): 83.7, 84.6) were very or somewhat willing to receive a COVID-19 vaccine; 15.9% (95% CI: 15.4, 16.3) were uncertain or very or somewhat unwilling. Based on logistic regression, those who were younger, female, had lower education and income, were non-White, and lived in a rural area were less willing to receive a COVID-19 vaccine. After controlling for these factors, recent receipt of influenza vaccine (adjusted odds ratio = 14.3, 95% CI: 12.5, 16.2) or planning to receive influenza vaccine (adjusted odds ratio = 10.5, 95% CI: 9.5, 11.6), as compared with no receipt or planning, was most strongly associated with COVID-19 vaccination willingness. Willingness was also associated with believing one had never been infected with severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) and experiencing negative pandemic consequences. Safety concerns were most common among those unwilling. Our comprehensive assessment of COVID-19 vaccination willingness among older adults in Canada, a prioritized group for vaccination due to their risk of severe COVID-19 outcomes, provides a road map for conducting outreach to increase uptake, which is urgently needed.
Original language | English |
---|---|
Pages (from-to) | 987-998 |
Number of pages | 12 |
Journal | American Journal of Epidemiology |
Volume | 191 |
Issue number | 6 |
DOIs | |
Publication status | Published - Jun 1 2022 |
Bibliographical note
Funding Information:Funding for the CLSA COVID-19 Questionnaire Study was provided by the Juravinski Research Institute, the Faculty of Health Sciences of McMaster University, the Provost Fund of McMaster University, the McMaster Institute for Research on Aging, the Public Health Agency of Canada, and the Nova Scotia COVID-19 Health Research Coalition. Funding for the CLSA is provided by the government of Canada through the Canadian Institutes of Health Research (grant LSA 94473) and the Canada Foundation for Innovation. N.E.B. holds a Tier 2 Canada Research Chair in Infectious Disease Prevention. L.E.G. is supported by the McLaughlin Foundation Professorship in Population and Public Health. P.R. holds the Raymond and Margaret Labarge Chair in Optimal Aging and Knowledge Application for Optimal Aging, is the Director of the McMaster Institute for Research on Aging and the Labarge Centre for Mobility in Aging, and holds a Tier 1 Canada Research Chair in Geroscience.
Publisher Copyright:
© 2022 The Author(s) 2022.
ASJC Scopus Subject Areas
- Epidemiology
PubMed: MeSH publication types
- Journal Article
- Research Support, Non-U.S. Gov't